Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease Patients Treated With Anti-CD20 Therapy: an Open-label Randomised Controlled Trial

NCT07818356 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT07818356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07818356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease Patients Treated With Anti-CD20 Therapy: an Open-label Randomised Controlled Trial
Lead sponsor
University Hospital, Toulouse
Phase
Phase 4
Overall status
Not yet recruiting
Start date
October 20, 2026
Completion date
November 30, 2030
Enrollment
160 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, spectrum disease neuromyelitis optica, vaccine, varicella-zoster virus